EPISODE · Jun 15, 2021 · 44 MIN
Akamai CEO, Twilio CEO & Homework: MindMedicine
from Mad Money w/ Jim Cramer · host CNBC
The Dow fell 94 points today and Jim Cramer’s highlighting some leaders in market. Then, Cramer‘s joined by Akamai’s CEO talking the rise of cyber attacks in the U.S. and how the 20 year old company plans to defend against them. Then, Twilio’s CEO discusses how they’re helping out in the vaccine front and how the business looks going forward. Plus, Cramer’s turning in his homework on MindMedicine, the company studying psychedelic drugs used as treatment for serious afflictions. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.
What this episode covers
The Dow fell 94 points today and Jim Cramer’s highlighting some leaders in market. Then, Cramer‘s joined by Akamai’s CEO talking the rise of cyber attacks in the U.S. and how the 20 year old company plans to defend against them. Then, Twilio’s CEO discusses how they’re helping out in the vaccine front and how the business looks going forward. Plus, Cramer’s turning in his homework on MindMedicine, the company studying psychedelic drugs used as treatment for serious afflictions.
NOW PLAYING
Akamai CEO, Twilio CEO & Homework: MindMedicine
No transcript for this episode yet
Similar Episodes
Apr 29, 2025 ·12m
Apr 27, 2025 ·11m
Apr 24, 2025 ·11m
Apr 22, 2025 ·14m